The Research Triangle Park-based biotechnology company, launched in 2017, confirmed it closed on $3.2 million to continue developing and scaling its microglassification dehydration process. The aim: to produce high-dosage, lower-volume medicines. Here are the details.
Read More
Lindy Biosciences, an RTP-based biotechnology startup, has raised more than $3.2 million in equity from 29 investors, and more could be on the way.
Read More
Lindy Biosciences, a biotech company developing innovative drug formulation technology that was bootstrapped by a loan from the North Carolina Biotechnology Center, has now completed a $1.6M Series A round.
Read More
Lindy Bio, a Southeast TechInventures spinout, closes on more than half a million for its unique biotherapeutics technology.
Read More
A Southeast Techinventures biologics spinout in Durham has raised about a third of a $1.6 million round.
Read MoreLindy Biosciences has raised $150,000, according to a securities filing.
Read More
